论文部分内容阅读
自 2 0 0 2年以来 ,哈药集团有限公司不断优化内部资源配置 ,强化体制创新和技术创新 ,积极调整资本结构、产品结构和市场结构 ,精心培育核心竞争力 ,使集团克服了主导产品价格连续下降、广告宣传受限、入世后市场竞争加剧等诸多不利因素 ,经济效益继续呈现快速增长的良好态势
Since 2002, Harbin Pharmaceutical Group Co., Ltd. has continuously optimized its internal resource allocation, strengthened institutional innovation and technological innovation, actively adjusted its capital structure, product structure and market structure, and carefully nurtured its core competitiveness so that the Group overcame its dominant product prices Continuous decline, limited advertising, after the accession to the WTO market competition intensified and many other unfavorable factors, the economic benefits continue to show a good momentum of rapid growth